ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 1 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $9,496,000 | +7.3% | 6,501,791 | +4.4% | 0.00% | 0.0% |
Q4 2016 | $8,847,000 | -14.0% | 6,228,914 | +6.0% | 0.00% | 0.0% |
Q3 2016 | $10,287,000 | +7.6% | 5,877,917 | +5.1% | 0.00% | 0.0% |
Q2 2016 | $9,557,000 | -30.6% | 5,590,158 | -20.0% | 0.00% | 0.0% |
Q1 2016 | $13,761,000 | -11.9% | 6,984,029 | -15.0% | 0.00% | -50.0% |
Q4 2015 | $15,619,000 | -57.2% | 8,218,848 | -1.6% | 0.00% | -50.0% |
Q1 2015 | $36,496,000 | +30.8% | 8,350,975 | +3.9% | 0.00% | +33.3% |
Q4 2014 | $27,905,000 | -12.0% | 8,041,257 | +6.3% | 0.00% | 0.0% |
Q3 2014 | $31,693,000 | -18.5% | 7,563,753 | +14.0% | 0.00% | -25.0% |
Q2 2014 | $38,896,000 | -14.3% | 6,637,729 | -7.9% | 0.00% | -20.0% |
Q1 2014 | $45,395,000 | -51.4% | 7,205,247 | -44.0% | 0.01% | -16.7% |
Q4 2013 | $93,383,000 | +124.4% | 12,870,326 | +63.0% | 0.01% | +20.0% |
Q3 2013 | $41,618,000 | -12.0% | 7,897,052 | +28.6% | 0.01% | -16.7% |
Q2 2013 | $47,289,000 | – | 6,141,696 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 867,700 | $3,636,000 | 1.05% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,847,999 | $24,503,000 | 0.89% |
MANGROVE PARTNERS IM, LLC | 210,900 | $884,000 | 0.26% |
Lyons Wealth Management, LLC. | 56,775 | $238,000 | 0.25% |
Callan Capital, LLC | 76,118 | $319,000 | 0.09% |
SABBY MANAGEMENT, LLC | 274,782 | $1,151,000 | 0.04% |
QS BATTERYMARCH FINANCIAL MANAGEMENT, INC | 338,703 | $1,420,000 | 0.04% |
WELLINGTON MANAGEMENT GROUP LLP | 29,627,959 | $124,141,000 | 0.03% |
Cambridge Investment Research Advisors, Inc. | 268,118 | $1,123,000 | 0.03% |
OppenheimerFunds, Inc. | 7,000,000 | $29,330,000 | 0.03% |